Tag: German

Studies

• Chemotherapy-induced cognitive impairment and its long-term development in patients with breast cancer: results from the observational CICARO study Cite
  Kerkmann A, Schinke C, Dordevic A, Kern J, Bangemann N, Finck J, et al. Chemotherapy-induced cognitive impairment and its long-term development in patients with breast cancer: results from the observational CICARO study. The Oncologist. Oxford University Press (OUP); 2024; 10.1093/oncolo/oyae268
• Physical activity levels are positively related to progression-free survival and reduced adverse events in advanced ER+ breast cancer Cite
  Zimmer P, Esser T, Lueftner D, Schuetz F, Baumann FT, Rody A, et al. Physical activity levels are positively related to progression-free survival and reduced adverse events in advanced ER+ breast cancer. BMC Medicine. Springer Science and Business Media LLC; 2024; 22 10.1186/s12916-024-03671-x
• Computerized cognitive training improves cognitive function in primary breast cancer survivors Cite
  Kleinknecht KR, Bierend M, Keim L, Bartels F, Lampit A, Finke C. Computerized cognitive training improves cognitive function in primary breast cancer survivors. npj Breast Cancer. Springer Science and Business Media LLC; 2024; 10 10.1038/s41523-024-00694-8
• HER2 Low Expression in Primary Male Breast Cancer Cite
  Nobbe K, Erices-Leclercq M, Foerster F, Förster R, Baldus S, Rudlowski C, et al. HER2 Low Expression in Primary Male Breast Cancer. Breast Cancer: Targets and Therapy. Informa UK Limited; 2024; Volume 16:141-148 10.2147/bctt.s450682
• Clinical impact of delaying initiation of adjuvant chemotherapy in patients with early triple negative breast cancer Cite
  Hatzipanagiotou ME, Pigerl M, Gerken M, Räpple S, Zeltner V, Hetterich M, et al. Clinical impact of delaying initiation of adjuvant chemotherapy in patients with early triple negative breast cancer. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2024; 10.1007/s10549-023-07207-4
• Effect of histological breast cancer subtypes invasive lobular versus non-special type on survival in early intermediate-to-high-risk breast carcinoma: results from the SUCCESS trials Cite
  Dayan D, Lukac S, Rack B, Ebner F, Fink V, Leinert E, et al. Effect of histological breast cancer subtypes invasive lobular versus non-special type on survival in early intermediate-to-high-risk breast carcinoma: results from the SUCCESS trials. Breast Cancer Research. Springer Science and Business Media LLC; 2023; 25 10.1186/s13058-023-01750-0
• Changes in the incidence of early-onset breast cancer in Germany between 2010 and 2022 Cite
  Gremke N, Wagner U, Kalder M, Kostev K. Changes in the incidence of early-onset breast cancer in Germany between 2010 and 2022. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2023; 10.1007/s10549-023-07048-1
• Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium Cite
  Kast K, John EM, Hopper JL, Andrieu N, Noguès C, Mouret-Fourme E, et al. Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium. Breast Cancer Research. Springer Science and Business Media LLC; 2023; 25 10.1186/s13058-023-01673-w
• 254P The invasive lobular cancer of the breast (ILC): A collection of clinical and pathological data in patients with (non-)metastatic breast cancer (BC) Cite
  Ljubicic T, Pross T, Dordevic A, Röhle R, Gebert P, Jank P, et al. 254P The invasive lobular cancer of the breast (ILC): A collection of clinical and pathological data in patients with (non-)metastatic breast cancer (BC). ESMO Open. Elsevier BV; 2023; 8:101442 10.1016/j.esmoop.2023.101442
• Discordance of HER2-low between primary tumors and matched distant metastases in breast cancer Cite
  Almstedt K, Krauthauser L, Kappenberg F, Wagner D, Heimes A, Battista MJ, et al. Discordance of HER2-low between primary tumors and matched distant metastases in breast cancer. Research Square Platform LLC; 2023; 10.21203/rs.3.rs-2478913/v1
• The Role of C-Reactive Protein as a Prognostic Biomarker in Patients with Early Breast Cancer Treated with Neoadjuvant Chemotherapy Cite
  Edimiris-Herrmann A, Kolberg-Liedtke C, Bittner A, Hoffmann O, Wetzig S, Shaheen M, et al. The Role of C-Reactive Protein as a Prognostic Biomarker in Patients with Early Breast Cancer Treated with Neoadjuvant Chemotherapy. Breast Care. S. Karger AG; 2022; 17:371-376 10.1159/000522606
• Antibiotic therapy is associated with an increased incidence of cancer Cite
  Roderburg C, Loosen SH, Joerdens MS, Demir M, Luedde T, Kostev K. Antibiotic therapy is associated with an increased incidence of cancer. Journal of Cancer Research and Clinical Oncology. Springer Science and Business Media LLC; 2022; 10.1007/s00432-022-03998-z
• Association of circulating leptin, adiponectin, and resistin concentrations with long-term breast cancer prognosis in a German patient cohort Cite
  Obi N, Jung AY, Maurer T, Huebner M, Johnson T, Behrens S, et al. Association of circulating leptin, adiponectin, and resistin concentrations with long-term breast cancer prognosis in a German patient cohort. Scientific Reports. Springer Science and Business Media LLC; 2021; 11 10.1038/s41598-021-02958-w
• Outcome of breast cancer patients with low hormone receptor positivity: Analysis of a 15-year population-based cohort Cite
  Schrodi S, Braun M, Andrulat A, Harbeck N, Mahner S, Kiechle M, et al. Outcome of breast cancer patients with low hormone receptor positivity: Analysis of a 15-year population-based cohort. Annals of Oncology. Elsevier BV; 2021; 10.1016/j.annonc.2021.08.1988
• Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment Cite
  Friedl TWP, Fehm T, Müller V, Lichtenegger W, Blohmer J, Lorenz R, et al. Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment. JAMA Oncology. American Medical Association (AMA); 2021; 10.1001/jamaoncol.2021.1854
• Efficacy of Endocrine Therapy for the Treatment of Breast Cancer in Men Cite
  Reinisch M, Seiler S, Hauzenberger T, Kamischke A, Schmatloch S, Strittmatter H, et al. Efficacy of Endocrine Therapy for the Treatment of Breast Cancer in Men. JAMA Oncology. American Medical Association (AMA); 2021; 10.1001/jamaoncol.2020.7442
• Comorbidity burden in long‐term breast cancer survivors compared with a cohort of population‐based controls from the MARIE study Cite
  Möhl A, Orban E, Jung AY, Behrens S, Obi N, Chang‐Claude J, et al. Comorbidity burden in long‐term breast cancer survivors compared with a cohort of population‐based controls from the MARIE study. Cancer. Wiley; 2020; 10.1002/cncr.33363
• Prognostic associations of circulating phytoestrogens and biomarker changes in long-term survivors of postmenopausal breast cancer Cite
  Jaskulski S, Jung AY, Huebner M, Poschet G, Hell R, Hüsing A, et al. Prognostic associations of circulating phytoestrogens and biomarker changes in long-term survivors of postmenopausal breast cancer. Nutrition and Cancer. Informa UK Limited; 2019; 72:1155-1169 10.1080/01635581.2019.1672762
• Association of dietary intake of milk and dairy products with blood concentrations of insulin-like growth factor 1 (IGF-1) in Bavarian adults Cite
  Romo Ventura E, Konigorski S, Rohrmann S, Schneider H, Stalla GK, Pischon T, et al. Association of dietary intake of milk and dairy products with blood concentrations of insulin-like growth factor 1 (IGF-1) in Bavarian adults. European Journal of Nutrition. Springer Science and Business Media LLC; 2019; 59:1413-1420 10.1007/s00394-019-01994-7
• Antioxidant supplementation and breast cancer prognosis in postmenopausal women undergoing chemotherapy and radiation therapy Cite
  Jung AY, Cai X, Thoene K, Obi N, Jaskulski S, Behrens S, et al. Antioxidant supplementation and breast cancer prognosis in postmenopausal women undergoing chemotherapy and radiation therapy. The American Journal of Clinical Nutrition. Oxford University Press (OUP); 2019; 109:69-78 10.1093/ajcn/nqy223
• Circulating enterolactone concentrations and prognosis of postmenopausal breast cancer: assessment of mediation by inflammatory markers Cite
  Jaskulski S, Jung AY, Behrens S, Johnson T, Kaaks R, Thöne K, et al. Circulating enterolactone concentrations and prognosis of postmenopausal breast cancer: assessment of mediation by inflammatory markers. International Journal of Cancer. Wiley; 2018; 143:2698-2708 10.1002/ijc.31647
• Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history Cite
  Engel C, Rhiem K, Hahnen E, Loibl S, Weber KE, Seiler S, et al. Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history. BMC Cancer. Springer Science and Business Media LLC; 2018; 18 10.1186/s12885-018-4029-y
• Enterolactone concentrations and prognosis after postmenopausal breast cancer: Assessment of effect modification and meta-analysis Cite
  Seibold P, Vrieling A, Johnson TS, Buck K, Behrens S, Kaaks R, et al. Enterolactone concentrations and prognosis after postmenopausal breast cancer: Assessment of effect modification and meta-analysis. International Journal of Cancer. Wiley; 2014; 135:923-933 10.1002/ijc.28729
• Routine treatment and outcome of breast cancer in younger versus elderly patients: results from the SENORA project of the prospective German TMK cohort study Cite
  Fietz T, Zahn M, Köhler A, Engel E, Frank M, Kruggel L, et al. Routine treatment and outcome of breast cancer in younger versus elderly patients: results from the SENORA project of the prospective German TMK cohort study. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 167:567-578 10.1007/s10549-017-4534-8
• Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials Cite
  van Mackelenbergh MT, Denkert C, Nekljudova V, Karn T, Schem C, Marmé F, et al. Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2017; 167:59-71 10.1007/s10549-017-4480-5
• Breast cancer and exposure to aircraft, road, and railway-noise: a case–control study based on health insurance records Cite
  Hegewald J, Schubert M, Wagner M, Dröge P, Prote U, Swart E, et al. Breast cancer and exposure to aircraft, road, and railway-noise: a case–control study based on health insurance records. Scandinavian Journal of Work, Environment & Health. Scandinavian Journal of Work, Environment and Health; 2017; 10.5271/sjweh.3665
• Impact of metformin on metastases in patients with breast cancer and type 2 diabetes Cite
  Jacob L, Kostev K, Rathmann W, Kalder M. Impact of metformin on metastases in patients with breast cancer and type 2 diabetes. Journal of Diabetes and its Complications. Elsevier BV; 2016; 30:1056-1059 10.1016/j.jdiacomp.2016.04.003
• Pre-diagnostic smoking behaviour and poorer prognosis in a German breast cancer patient cohort – Differential effects by tumour subtype, NAT2 status, BMI and alcohol intake Cite
  Seibold P, Vrieling A, Heinz J, Obi N, Sinn H, Flesch-Janys D, et al. Pre-diagnostic smoking behaviour and poorer prognosis in a German breast cancer patient cohort – Differential effects by tumour subtype, NAT2 status, BMI and alcohol intake. Cancer Epidemiology. Elsevier BV; 2014; 38:419-426 10.1016/j.canep.2014.05.006
• Estrogenic activity of constituents of underarm deodorants determined by E-Screen assay Cite
  Lange C, Kuch B, Metzger JW. Estrogenic activity of constituents of underarm deodorants determined by E-Screen assay. Chemosphere. Elsevier BV; 2014; 108:101-106 10.1016/j.chemosphere.2014.02.082
• Enterolactone concentrations and prognosis after postmenopausal breast cancer: Assessment of effect modification and meta-analysis Cite
  Seibold P, Vrieling A, Johnson TS, Buck K, Behrens S, Kaaks R, et al. Enterolactone concentrations and prognosis after postmenopausal breast cancer: Assessment of effect modification and meta-analysis. International Journal of Cancer. Wiley; 2014; 135:923-933 10.1002/ijc.28729
• Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors? Cite
  Vrieling A, Seibold P, Johnson TS, Heinz J, Obi N, Kaaks R, et al. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?. International Journal of Cancer. Wiley; 2013; 134:2972-2983 10.1002/ijc.28628
• Dietary patterns and survival in German postmenopausal breast cancer survivors Cite
  Vrieling A, Buck K, Seibold P, Heinz J, Obi N, Flesch-Janys D, et al. Dietary patterns and survival in German postmenopausal breast cancer survivors. British Journal of Cancer. Springer Science and Business Media LLC; 2012; 108:188-192 10.1038/bjc.2012.521
• Mutation Analysis of BRCA1, BRCA2, PALB2 and BRD7 in a Hospital-Based Series of German Patients with Triple-Negative Breast Cancer Cite
  Pern F, Bogdanova N, Schürmann P, Lin M, Ay A, Länger F, et al. Mutation Analysis of BRCA1, BRCA2, PALB2 and BRD7 in a Hospital-Based Series of German Patients with Triple-Negative Breast Cancer. PLoS ONE. Public Library of Science (PLoS); 2012; 7:e47993 10.1371/journal.pone.0047993
• Abstract 3580: Pre-diagnostic alcohol consumption and breast cancer recurrence and survival in postmenopausal women Cite
  Chang-Claude JC. Abstract 3580: Pre-diagnostic alcohol consumption and breast cancer recurrence and survival in postmenopausal women. Epidemiology. American Association for Cancer Research; 2012; 10.1158/1538-7445.am2012-3580
• Health-related quality of life in breast cancer patients: A bibliographic review of the literature from 1974 to 2007 Cite
  Montazeri A. Health-related quality of life in breast cancer patients: A bibliographic review of the literature from 1974 to 2007. Journal of Experimental & Clinical Cancer Research. Springer Science and Business Media LLC; 2008; 27 10.1186/1756-9966-27-32
• Estimated enterolignans, lignan-rich foods, and fibre in relation to survival after postmenopausal breast cancer Cite
  Buck K, Zaineddin AK, Vrieling A, Heinz J, Linseisen J, Flesch-Janys D, et al. Estimated enterolignans, lignan-rich foods, and fibre in relation to survival after postmenopausal breast cancer. British Journal of Cancer. Springer Science and Business Media LLC; 2011; 105:1151-1157 10.1038/bjc.2011.374
• Serum Enterolactone and Prognosis of Postmenopausal Breast Cancer Cite
  Buck K, Vrieling A, Zaineddin AK, Becker S, Hüsing A, Kaaks R, et al. Serum Enterolactone and Prognosis of Postmenopausal Breast Cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011; 29:3730-3738 10.1200/jco.2011.34.6478
• Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status Cite
  Zaineddin AK, Vrieling A, Buck K, Becker S, Linseisen J, Flesch-Janys D, et al. Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status. International Journal of Cancer. Wiley; 2011; 130:1401-1410 10.1002/ijc.26157
• Do patients with invasive lobular breast cancer benefit in terms of adequate change in surgical therapy from a supplementary preoperative breast MRI? Cite
  Heil J, Buehler A, Golatta M, Rom J, Schipp A, Harcos A, et al. Do patients with invasive lobular breast cancer benefit in terms of adequate change in surgical therapy from a supplementary preoperative breast MRI?. Annals of Oncology. Elsevier BV; 2012; 23:98-104 10.1093/annonc/mdr064
• Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials Cite
  von Minckwitz G, Untch M, Nüesch E, Loibl S, Kaufmann M, Kümmel S, et al. Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2010; 125:145-156 10.1007/s10549-010-1228-x
• Long-term strict raw food diet is associated with favourable plasma β-carotene and low plasma lycopene concentrations in Germans Cite
  Garcia AL, Koebnick C, Dagnelie PC, Strassner C, Elmadfa I, Katz N, et al. Long-term strict raw food diet is associated with favourable plasma β-carotene and low plasma lycopene concentrations in Germans. British Journal of Nutrition. Cambridge University Press (CUP); 2008; 99:1293-1300 10.1017/s0007114507868486
• The Use of Herbal Preparations to Alleviate Climacteric Disorders and Risk of Postmenopausal Breast Cancer in a German Case-Control Study Cite
  Obi N, Chang-Claude J, Berger J, Braendle W, Slanger T, Schmidt M, et al. The Use of Herbal Preparations to Alleviate Climacteric Disorders and Risk of Postmenopausal Breast Cancer in a German Case-Control Study. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2009; 18:2207-2213 10.1158/1055-9965.epi-09-0298
• Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study Cite
  Linseisen J, Piller R, Hermann S, Chang-Claude J. Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study. International Journal of Cancer. Wiley; 2004; 110:284-290 10.1002/ijc.20119
• Dietary intake of meat and meat-derived heterocyclic aromatic amines and their correlation with DNA adducts in female breast tissue Cite
  Rohrmann S, Lukas Jung S, Linseisen J, Pfau W. Dietary intake of meat and meat-derived heterocyclic aromatic amines and their correlation with DNA adducts in female breast tissue. Mutagenesis. Oxford University Press (OUP); 2008; 24:127-132 10.1093/mutage/gen058